Stein Steven H
CMO & Head of Late-Stage Dev. at INCY
- Sold, on record
- $28.4M
- Dollars the filings state
- Form 4 sales
- 22
- Latest Nov 16, 2026
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- INCYINCYTE CORPCMO & Head of Late-Stage Dev.
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale INCYRoutineJul 14 2025
Sold 14,952 shares at $68.47 ($1M)
Stein Steven H, EVP & Chief Medical Officer
10b5-1 planSold 13.3% of holdings ($7.7M position)97,466 shares left1.2x usual sizeFiling
- 2 Form 4 sale INCYRoutineJul 21 +7 days
Sold 3,706 shares at $67.94 ($252k)
Stein Steven H, EVP & Chief Medical Officer
10b5-1 planSold 3.5% of holdings ($7.2M position)102,886 shares left0.3x usual sizeFiling
- 3 Form 4 sale INCYRoutineNov 5 +107 days
Sold 5,233 shares at $102.20 ($535k)
Stein Steven H, EVP & Chief Medical Officer
10b5-1 planSold 4.8% of holdings ($11M position)102,886 shares left0.5x usual sizeFiling
- 4 Form 4 sale INCYRoutineDec 2 +27 days
Sold 22,664 shares at $102.56 ($2.3M)
Stein Steven H, EVP & Chief Medical Officer
10b5-1 planSold 26.4% of holdings ($8.8M position)63,129 shares left2.4x usual sizeFiling
- 5 Form 4 sale INCYRoutineJan 5 +34 days
Sold 15,634 shares at $101.70 ($1.6M)
Stein Steven H, EVP & Chief Medical Officer
10b5-1 planSold 31.4% of holdings ($5.1M position)34,203 shares left1.3x usual sizeFiling
- 6 Form 4 sale INCYRoutineJul 15 +191 days
Sold 28,237 shares at $113.05 ($3.2M)
Stein Steven H, CMO & Head of Late-Stage Dev.
10b5-1 planSold 52% of holdings ($6.1M position)26,083 shares left2.3x usual sizeFiling
- 7 Form 4 sale INCYRoutineJul 16 +1 day
Sold 1,877 shares at $114.73 ($215k)
Stein Steven H, CMO & Head of Late-Stage Dev.
10b5-1 planSold 8.2% of holdings ($2.6M position)21,118 shares left0.1x usual sizeFiling
- 8 Form 4 sale INCYRoutineNov 16 +123 days
Sold 576 shares at $121.98 ($70k)
Stein Steven H, CMO & Head of Late-Stage Dev.
10b5-1 planSold 1.8% of holdings ($3.8M position)30,916 shares left0x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (25)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | INCY | CMO & Head of Late-Stage Dev. | Form 4 sale | 576 | $70k | 1.8% | Routine | SEC |
| Jul 16, 2026 | INCY | CMO & Head of Late-Stage Dev. | Form 4 sale | 1,877 | $215k | 8.2% | Routine | SEC |
| Jul 15, 2026 | INCY | CMO & Head of Late-Stage Dev. | Form 4 sale | 28,237 | $3.2M | 52.0% | Routine | SEC |
| Jan 5, 2026 | INCY | EVP & Chief Medical Officer | Form 4 sale | 15,634 | $1.6M | 31.4% | Routine | SEC |
| Dec 2, 2025 | INCY | EVP & Chief Medical Officer | Form 4 sale | 22,664 | $2.3M | 26.4% | Routine | SEC |
| Nov 5, 2025 | INCY | EVP & Chief Medical Officer | Form 4 sale | 5,233 | $535k | 4.8% | Routine | SEC |
| Jul 21, 2025 | INCY | EVP & Chief Medical Officer | Form 4 sale | 3,706 | $252k | 3.5% | Routine | SEC |
| Jul 14, 2025 | INCY | EVP & Chief Medical Officer | Form 4 sale | 14,952 | $1M | 13.3% | Routine | SEC |
| Jan 21, 2025 | INCY | EVP & Chief Medical Officer | Form 4 sale | 12,352 | $898k | 15.6% | Routine | SEC |
| Aug 12, 2024 | INCY | EVP & Chief Medical Officer | Form 4 sale | 11,608 | $704k | 11.4% | Routine | SEC |
| Aug 12, 2024 | INCY | Officer | Form 144 notice | 11,608 | $704k | Notice | SEC | |
| Jan 3, 2024 | INCY | EVP & Chief Medical Officer | Form 4 sale | 7,365 | $482k | 7.5% | Routine | SEC |
| Jan 3, 2024 | INCY | Officer | Form 144 notice | 7,365 | $482k | Notice | SEC | |
| Aug 1, 2023 | INCY | EVP & Chief Medical Officer | Form 4 sale | 21,511 | $1.4M | 18.1% | Routine | SEC |
| Aug 1, 2023 | INCY | Officer | Form 144 notice | 21,511 | $1.4M | Notice | SEC | |
| Jan 4, 2023 | INCY | EVP & Chief Medical Officer | Form 4 sale | 28,399 | $2.3M | 20.7% | Plan not stated | SEC |
| Jan 25, 2021 | INCY | EVP & Chief Medical Officer | Form 4 sale | 3,795 | $380k | 3.1% | Plan not stated | SEC |
| Jul 16, 2020 | INCY | EVP & Chief Medical Officer | Form 4 sale | 766 | $80k | 0.8% | Plan not stated | SEC |
| Jul 8, 2020 | INCY | EVP & Chief Medical Officer | Form 4 sale | 14,769 | $1.6M | 13.2% | Plan not stated | SEC |
| Jul 6, 2020 | INCY | EVP & Chief Medical Officer | Form 4 sale | 36,124 | $3.9M | 26.4% | Unusual | SEC |
| Jun 24, 2019 | INCY | EVP & Chief Medical Officer | Form 4 sale | 8,357 | $735k | 43.6% | Unusual | SEC |
| Aug 29, 2017 | INCY | EVP & Chief Medical Officer | Form 4 sale | 2,111 | $264k | 10.4% | Plan not stated | SEC |
| Jul 20, 2017 | INCY | EVP & Chief Medical Officer | Form 4 sale | 6,485 | $850k | 26.3% | Unusual | SEC |
| Jun 20, 2017 | INCY | EVP & Chief Medical Officer | Form 4 sale | 9,883 | $1.2M | 40.3% | Unusual | SEC |
| Apr 7, 2017 | INCY | EVP & Chief Medical Officer | Form 4 sale | 32,000 | $4.4M | 68.6% | Unusual | SEC |